ZAULI, Giorgio
 Distribuzione geografica
Continente #
NA - Nord America 19.948
EU - Europa 5.092
AS - Asia 2.605
SA - Sud America 31
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 4
Totale 27.698
Nazione #
US - Stati Uniti d'America 19.912
CN - Cina 1.672
UA - Ucraina 1.213
IT - Italia 1.083
DE - Germania 782
TR - Turchia 781
PL - Polonia 731
GB - Regno Unito 528
FI - Finlandia 266
SE - Svezia 262
FR - Francia 65
VN - Vietnam 64
RU - Federazione Russa 57
BE - Belgio 34
CA - Canada 30
BR - Brasile 26
IN - India 23
HK - Hong Kong 21
IR - Iran 18
NL - Olanda 17
AU - Australia 11
IE - Irlanda 8
RO - Romania 8
ES - Italia 7
CH - Svizzera 5
MX - Messico 5
TW - Taiwan 5
CZ - Repubblica Ceca 4
EU - Europa 4
JP - Giappone 4
NO - Norvegia 4
SG - Singapore 4
BG - Bulgaria 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
CL - Cile 2
DK - Danimarca 2
GE - Georgia 2
GR - Grecia 2
ID - Indonesia 2
IL - Israele 2
MD - Moldavia 2
MY - Malesia 2
A1 - Anonimo 1
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
DZ - Algeria 1
EG - Egitto 1
HN - Honduras 1
IQ - Iraq 1
KR - Corea 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MC - Monaco 1
MK - Macedonia 1
NG - Nigeria 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
VE - Venezuela 1
Totale 27.698
Città #
Fairfield 3.039
Woodbridge 2.826
Houston 1.729
Ashburn 1.432
Jacksonville 1.381
Ann Arbor 1.270
Chandler 1.231
Seattle 1.182
Cambridge 1.065
Wilmington 1.057
Warsaw 724
Izmir 487
Nanjing 388
Ferrara 383
Beijing 340
Princeton 311
San Diego 240
Boardman 226
New York 134
Shanghai 129
Shenyang 128
Nanchang 123
Milan 121
Dearborn 110
Tianjin 75
Changsha 72
Hebei 70
Jiaxing 63
Dong Ket 62
Falls Church 61
Mountain View 60
Bremen 55
Jinan 52
Los Angeles 51
San Mateo 50
Norwalk 48
Kunming 45
Zhengzhou 43
Auburn Hills 42
Redwood City 38
London 34
Brussels 33
Tappahannock 33
Orange 31
Addison 23
Bologna 22
Guangzhou 22
Rome 22
Munich 21
Philadelphia 20
Washington 20
Leawood 19
Hong Kong 18
Ningbo 18
Augusta 17
Des Moines 17
Ferrara di Monte Baldo 17
Indiana 16
Sanayi 16
Scottsdale 16
Changchun 15
Helsinki 15
Verona 15
Haikou 13
Hangzhou 12
Montréal 12
Ardabil 11
Kilburn 11
Redmond 11
Taizhou 11
Padova 10
Lanzhou 9
San Francisco 9
Trieste 9
Hounslow 8
Chicago 7
Genoa 7
Hefei 7
Imola 7
Monmouth Junction 7
Wuhan 7
Andover 6
Bari 6
Dallas 6
Dronten 6
Florence 6
Ottawa 6
Toronto 6
Forlì 5
Fuzhou 5
New Bedfont 5
Taipei 5
Walnut 5
Chiswick 4
Conzano 4
Desio 4
Mcallen 4
Monselice 4
New Delhi 4
Phoenix 4
Totale 21.686
Nome #
Trattato di Anatomia Umana 235
Targeting mTOR in Acute Lymphoblastic Leukemia 207
Trattato di Anatomia Umana 203
Targeting the phosphatidylinositol 3-kinase/Akt/mechanistic target of rapamycin signaling pathway in B-lineage acute lymphoblastic leukemia: An update 174
Intranasal Administration of Recombinant TRAIL Down-Regulates CXCL-1/KC in an Ovalbumin-Induced Airway Inflammation Murine Model 173
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 165
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 164
PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines 162
Cytokine levels in the serum of healthy subjects 159
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 159
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells 157
Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in Cognitive Impairment Diseases 154
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 152
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 152
MDM2/X inhibitors under clinical evaluation: Perspectives for the management of hematological malignancies and pediatric cancer 147
Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging 147
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 146
Impact of physical exercise in cancer survivors during and after antineoplastic treatments 146
Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia 144
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 140
Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia 138
Cardiovascular disease-related miRNAs expression: Potential role as biomarkers and effects of training exercise 138
Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells 137
Changes of nuclear protein kinase C activity and isotype composition in PC12 cell proliferation and differentiation 135
Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia 135
Multiple dye-doped NIR-emitting silica nanoparticles for both flow cytometry and in vivo imaging 134
The circulating levels of TRAIL are extremely low after delivery but rapidly recover in both mothers and newborns 134
Multimodal near-infrared-emitting PluS Silica nanoparticles with fluorescent, photoacoustic, and photothermal capabilities 132
HelixComplex snail mucus exhibits pro-survival, proliferative and pro-migration effects on mammalian fibroblasts 131
Stroma-derived factor 1alpha induces a selective inhibition of human erythroid development via the functional upregulation of Fas/CD95 ligand. 128
null 128
Association of serum tumor necrosis factor-related apoptosis inducing ligand with body fat distribution as assessed by dual X-rays absorptiometry 126
Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-hodgkin's lymphoma xenografts 125
Antiangiogenic activity of the MDM2 antagonist nutlin-3 125
Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53(wild-type) JVM-2 But Not Towards p53(mutated) BJAB Leukemic Cells 124
Nutlin-3 upregulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feed-back anti-apoptotic mechanism 123
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 123
Lovastatin dose-dependently potentiates the pro-inflammatory activity of lipopolysaccharide both in vitro and in vivo 123
An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently tat-transfected cells and required for optimal HIV-1 LTR transactivating activity 123
Two-gene mutation in a single patient: Biochemical and functional analysis for a correct interpretation of exome results 123
Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments 123
In vivo anti-lymphoma activity of an agonistic human recombinant anti-TRAIL-R2 minibody. 121
Proper design of silica nanoparticles combines high brightness, lack of cytotoxicity and efficient cell endocytosis 120
TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release 119
Serum Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Levels in Older Subjects with Dementia and Mild Cognitive Impairment 119
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease 119
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 118
HIV-1 Tat protein down-regulates CREB transcription factor expression in PC12 neuronal cells through a phosphatidylinositol 3-kinase/AKT/cyclic nucleoside phosphodiesterase pathway 117
In vitro growth of human fetal CD34+ cells in the presence of various combinations of recombinant cytokines under serum-free culture conditions 117
Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes 116
Clinical perspectives of TRAIL: Insights into central nervous system disorders 116
HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells 115
The MDM2 inhibitor Nutlin-3 attenuates streptozotocin-induced diabetes mellitus and increases serum level of IL-12p40. 115
Association of Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) with Central Adiposity and Low-Density Lipoprotein Cholesterol 115
Redox signaling and oxidative stress: Cross talk with TNF-related apoptosis inducing ligand activity 115
Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults 115
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets 115
Role of CREB transcription factor in c-fos activation in natural killer cells. 113
Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+ T cell hyperactivation and HIV type 1 replication 113
Association between thyroid hormones and TRAIL 113
Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy 113
All-trans retinoic acid shows multiple effects on the survival, proliferation and differentiation of human fetal CD34+ haemopoietic progenitor cells. 112
Cell-based therapies for diabetic complications. 112
Circulating levels of TNF-related apoptosis inducing-ligand are decreased in patients with large adult-type granulosa cell tumors—implications for therapeutic potential 112
TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress 112
Human Herpesvirus 7 infection induces profound cell cycle perturbations coupled to disregulation of cdc2 and cyclin B and polyploidization of CD4+ T Cells 111
TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications 111
Inflammation and Cardiovascular Cross Talk in Ischemic Vascular Diseases 111
Actively targeted nanocarriers for drug delivery to cancer cells 111
Low Circulating TRAIL Levels Are Associated with Increase of Resistin and Lipocalin-2/ngal Adipokines in Postmenopausal Women 110
Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells 109
JCV plus Patients with Inflammatory Bowel Disease show elevated plasma levels of MIG and SCF 108
GM-CSF Exhibits Anti-Inflammatory Activity on Endothelial Cells Derived from Chronic Venous Disease Patients 108
State of art and recent developments of anti-cancer strategies based on TRAIL 108
The MDM-2 antagonist nutlin-3 promotes the maturation of acute myeloid leukemic blasts 107
Molecular targets for selective killing of TRAIL-resistant leukemic cells. 107
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL) 107
COVID-19 and individual genetic susceptibility/receptivity: Role of ACE1/ACE2 genes, immunity, inflammation and coagulation. might the double x-chromosome in females be protective against SARS-COV-2 compared to the single x-chromosome in males? 107
HIV-1 Tat induces tyrosine phosphorylation of p125FAK and its association with phosphoinositide 3-kinase in PC12 cells. 106
Human herpesvirus type 7 in Hodgkin's disease 106
TRAIL, a New Weapon against Neointimal Hyperplasia 106
Roles and clinical implications of microRNAs in acute lymphoblastic leukemia 106
Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells 105
null 105
Circulating levels of frizzled-related protein (FRZB) are increased in patients with early rheumatoid arthritis and decrease in response to disease-modifying antirheumatic drugs. 105
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells 105
Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye 105
A Brain Hidden in the Ferrara Cathedral: A Novel Interpretation of a Renaissance Masterpiece 105
null 104
Mesenchymal stem cells display hepato-protective activity in lymphoma bearing xenografts 104
Influence of physical exercise on microRNAs in skeletal muscle regeneration, aging and diseases 104
Nuclear translocation of protein kinase C-α and -ζ isoforms in HL-60 cells induced to differentiate along the granulocytic lineage by all-trans retinoic acid 104
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) regulates endothelial nitric oxide synthase (eNOS) activity and its localization within the human vein endothelial cells (HUVEC) in culture 103
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells 103
Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70 103
null 102
Circulating TRAIL shows a significant post-partum decline associated to stressful conditions. 102
The CD4 receptor plays essential but distinct roles in HIV‐1 infection and induction of apoptosis in primary bone marrow GPIIb/IIIa+ megakaryocytes and the HEL cell line 102
HIV-1 Tat protein concomitantly down-regulates apical caspase-10 and up-regulates c-FLIP in lymphoid T cells: A potential molecular mechanism to escape TRAIL cytotoxicity 101
MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway 101
Totale 12.468
Categoria #
all - tutte 96.161
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.294
Totale 97.455


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193.276 0 0 0 0 0 0 0 0 0 723 990 1.563
2019/20207.113 1.009 264 267 1.054 528 830 690 737 624 641 278 191
2020/20215.096 342 413 213 558 430 546 262 595 177 718 526 316
2021/20223.048 109 312 243 136 158 180 158 177 119 257 363 836
2022/20233.019 334 136 119 357 462 472 103 271 387 52 186 140
2023/20241.088 179 207 73 42 106 195 61 147 42 36 0 0
Totale 28.277